PL2794618T3 - lzotiazolopirydyno-2-karboksyamidy i ich zastosowanie jako farmaceutyki - Google Patents
lzotiazolopirydyno-2-karboksyamidy i ich zastosowanie jako farmaceutykiInfo
- Publication number
- PL2794618T3 PL2794618T3 PL12806043T PL12806043T PL2794618T3 PL 2794618 T3 PL2794618 T3 PL 2794618T3 PL 12806043 T PL12806043 T PL 12806043T PL 12806043 T PL12806043 T PL 12806043T PL 2794618 T3 PL2794618 T3 PL 2794618T3
- Authority
- PL
- Poland
- Prior art keywords
- isothiazolopyridine
- carboxamides
- pharmaceuticals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306711 | 2011-12-20 | ||
| EP12806043.1A EP2794618B1 (en) | 2011-12-20 | 2012-12-18 | Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2794618T3 true PL2794618T3 (pl) | 2017-05-31 |
Family
ID=47429823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12806043T PL2794618T3 (pl) | 2011-12-20 | 2012-12-18 | lzotiazolopirydyno-2-karboksyamidy i ich zastosowanie jako farmaceutyki |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9260454B2 (pl) |
| EP (1) | EP2794618B1 (pl) |
| JP (1) | JP6099669B2 (pl) |
| KR (1) | KR20140103150A (pl) |
| CN (1) | CN104136443B (pl) |
| AR (1) | AR089329A1 (pl) |
| AU (1) | AU2012357864B2 (pl) |
| BR (1) | BR112014015033A2 (pl) |
| CA (1) | CA2856964A1 (pl) |
| CY (1) | CY1118854T1 (pl) |
| DK (1) | DK2794618T3 (pl) |
| ES (1) | ES2613826T3 (pl) |
| HK (1) | HK1198587A1 (pl) |
| HR (1) | HRP20170159T1 (pl) |
| HU (1) | HUE033049T2 (pl) |
| IL (1) | IL232809A (pl) |
| LT (1) | LT2794618T (pl) |
| MX (1) | MX2014007465A (pl) |
| PL (1) | PL2794618T3 (pl) |
| PT (1) | PT2794618T (pl) |
| RU (1) | RU2014129903A (pl) |
| SG (1) | SG11201402623RA (pl) |
| SI (1) | SI2794618T1 (pl) |
| WO (1) | WO2013092574A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6814730B2 (ja) * | 2014-09-05 | 2021-01-20 | ジェネンテック， インコーポレイテッド | 治療用化合物およびその使用 |
| US10011611B2 (en) * | 2015-08-14 | 2018-07-03 | Reaction Biology Corp. | Histone deacetylase inhibitors and methods for use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3892745A (en) * | 1972-11-20 | 1975-07-01 | Sankyo Co | Isoxazolone derivatives and process for preparing the same |
| US3965107A (en) | 1974-07-08 | 1976-06-22 | Rohm And Haas Company | Isothiazolopyridinones |
| LU84091A1 (fr) * | 1982-04-16 | 1984-03-02 | Oreal | Derives n-carbamoyl d'isothiazolo-(5,4b)pyridine one-3,leur procede de preparation et leurs utilisations comme agents bactericides et fongicides |
| US4968713A (en) | 1989-07-31 | 1990-11-06 | Merck & Co., Inc. | Certain imidazole compounds as transglutaminase inhibitors |
| DE10054687A1 (de) | 2000-11-03 | 2002-05-16 | N Zyme Biotec Gmbh | Inhibitoren von Transglutaminasen |
| EP1613608A1 (en) * | 2003-04-01 | 2006-01-11 | Eli Lilly And Company | Phospholipase inhibitors |
| WO2004094394A1 (en) * | 2003-04-01 | 2004-11-04 | Eli Lilly And Company | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
| GB0314262D0 (en) | 2003-06-19 | 2003-07-23 | Univ Nottingham Trent | Novel compounds and methods of using the same |
| WO2005089753A2 (en) * | 2004-03-16 | 2005-09-29 | Janssen Pharmaceutica N.V. | Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders |
| DE102006014688A1 (de) | 2006-03-28 | 2007-10-04 | Sanofi-Aventis | Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
| DE102006052755A1 (de) | 2006-11-08 | 2008-05-15 | N-Zyme Biotec Gmbh | Michaelsysteme als Transglutaminaseinhibitoren |
| US8946197B2 (en) | 2009-11-16 | 2015-02-03 | Chdi Foundation, Inc. | Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof |
| WO2011157827A1 (de) * | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
-
2012
- 2012-12-18 RU RU2014129903A patent/RU2014129903A/ru not_active Application Discontinuation
- 2012-12-18 JP JP2014547921A patent/JP6099669B2/ja not_active Expired - Fee Related
- 2012-12-18 SG SG11201402623RA patent/SG11201402623RA/en unknown
- 2012-12-18 WO PCT/EP2012/075932 patent/WO2013092574A1/en active Application Filing
- 2012-12-18 DK DK12806043.1T patent/DK2794618T3/en active
- 2012-12-18 CN CN201280070206.0A patent/CN104136443B/zh not_active Expired - Fee Related
- 2012-12-18 BR BR112014015033A patent/BR112014015033A2/pt not_active IP Right Cessation
- 2012-12-18 SI SI201230855A patent/SI2794618T1/sl unknown
- 2012-12-18 KR KR1020147019341A patent/KR20140103150A/ko not_active Application Discontinuation
- 2012-12-18 PL PL12806043T patent/PL2794618T3/pl unknown
- 2012-12-18 CA CA2856964A patent/CA2856964A1/en not_active Abandoned
- 2012-12-18 AU AU2012357864A patent/AU2012357864B2/en not_active Ceased
- 2012-12-18 EP EP12806043.1A patent/EP2794618B1/en active Active
- 2012-12-18 LT LTEP12806043.1T patent/LT2794618T/lt unknown
- 2012-12-18 ES ES12806043.1T patent/ES2613826T3/es active Active
- 2012-12-18 MX MX2014007465A patent/MX2014007465A/es unknown
- 2012-12-18 PT PT128060431T patent/PT2794618T/pt unknown
- 2012-12-18 HU HUE12806043A patent/HUE033049T2/hu unknown
- 2012-12-19 AR ARP120104822A patent/AR089329A1/es unknown
-
2014
- 2014-05-26 IL IL232809A patent/IL232809A/en not_active IP Right Cessation
- 2014-06-18 US US14/307,961 patent/US9260454B2/en active Active
- 2014-12-01 HK HK14112083A patent/HK1198587A1/xx not_active IP Right Cessation
-
2017
- 2017-02-01 HR HRP20170159TT patent/HRP20170159T1/hr unknown
- 2017-02-15 CY CY20171100208T patent/CY1118854T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104136443A (zh) | 2014-11-05 |
| HUE033049T2 (hu) | 2017-11-28 |
| AR089329A1 (es) | 2014-08-13 |
| DK2794618T3 (en) | 2017-02-20 |
| SI2794618T1 (sl) | 2017-03-31 |
| AU2012357864A1 (en) | 2014-07-03 |
| JP2015500855A (ja) | 2015-01-08 |
| SG11201402623RA (en) | 2014-09-26 |
| WO2013092574A1 (en) | 2013-06-27 |
| IL232809A0 (en) | 2014-08-03 |
| CA2856964A1 (en) | 2013-06-27 |
| KR20140103150A (ko) | 2014-08-25 |
| EP2794618A1 (en) | 2014-10-29 |
| EP2794618B1 (en) | 2016-11-16 |
| ES2613826T3 (es) | 2017-05-26 |
| HK1198587A1 (en) | 2015-04-30 |
| RU2014129903A (ru) | 2016-02-10 |
| AU2012357864B2 (en) | 2017-03-02 |
| BR112014015033A2 (pt) | 2017-06-13 |
| US20140296169A1 (en) | 2014-10-02 |
| PT2794618T (pt) | 2017-01-17 |
| CY1118854T1 (el) | 2018-01-10 |
| MX2014007465A (es) | 2014-07-30 |
| LT2794618T (lt) | 2017-02-27 |
| US9260454B2 (en) | 2016-02-16 |
| JP6099669B2 (ja) | 2017-03-22 |
| IL232809A (en) | 2017-05-29 |
| CN104136443B (zh) | 2017-01-18 |
| HRP20170159T1 (hr) | 2017-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100012I1 (hu) | 4-Imidazopiridazin-1-il-benzamidok és 4-imidazotriazin-1-il-benzamidok mint BTK-gátlók | |
| IL233051B (en) | Anti-phf-tau antibodies and uses thereof | |
| IL229844B (en) | Anti-psgl-1 antibodies and their use | |
| GB201111705D0 (en) | Compounds and their use | |
| HK1191034A1 (en) | N-carboxyalkyl-auristatins and use thereof n- | |
| HK1225714A1 (zh) | 3-雜芳酰基氨基-丙酸衍生物及其作為藥物的用途 | |
| EP2718283A4 (en) | INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | |
| GB201111630D0 (en) | Novel compounds and their use | |
| GB201114448D0 (en) | Compounds and their use | |
| EP2693879A4 (en) | MIGRASTATINES AND THEIR USES | |
| HRP20160687T1 (hr) | Supstituirani 2-(kroman-6-iloksi)tiazoli i njihova upotreba kao farmaceutska sredstva | |
| IL232809A0 (en) | Carboxamides converted at position 2 in isothiazolopyridine and their use as medicinal preparations | |
| IL231096A (en) | Theses are converted into 2- (novel-6-Iloxy) and used as pharmaceutical preparations | |
| ME03310B (me) | 4-IMIDAZOPIRIDAZIN-1-jL-BENZAMIDI I 4-IMIDAZOTRIAZIN-1-IL-BENZAMIDl КАО INHIBITORI втк | |
| GB201104444D0 (en) | Compounds and their use |